InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by KAY CHRISTINA. Director active across 1 company, notably Integrated Biopharma INC. Cumulatively, 4 filings have been logged. Activity tracked since 30 May 2023. The latest transaction was disclosed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations